Piramal Pharma Solutions, part of Piramal Enterprises, has appointed John Fowler as its Chief Operating Officer.
Fowler will be responsible for global operations and research and development, Piramal Pharma Solutions said in a statement.
“With our customers increasingly choosing Piramal as their ‘Partner of Choice’ to progress their assets from discovery towards commercialisation, John’s track record of aligning services and talent towards a common vision is one that the PPS team can benefit from,” Piramal Pharma Solutions (PPS) CEO Vivek Sharma said.
As PPS enters the next phase of growth, it is important that the company brings in executives with international experience and expertise, he added.
“As our customers seek dependable partners that can offer seamless and integrated solutions, from discovery through commercialisation, from drug substance to drug product, I look forward to positioning PPS to deliver on these needs and build long-term, sustainable and strategic partnerships,” Fowler said.
Most recently, Fowler served as the divisional CEO of the Global Fine Chemicals business at Johnson Matthey.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.